Abstract
Purpose
To investigate the mediators of health-related quality of life (HR-QoL) in colorectal cancer (CRC) patients and effect on overall survival.
Methods
We analyzed baseline (within 1 year of diagnosis) SF-12v1 questionnaire data from 3734 CRC patients and assessed the differences in mental composite scores (MCS) and physical composite scores (PCS) by socio-demographics and risks of poor HR-QoL by these factors. Hazard ratios were generated using univariate Cox regression for MCS and PCS dichotomized using the normalized scoring-based mean of 50 and survival estimates generated using the Kaplan–Meier method.
Results
Differences in MCS and PCS were identified by sex, age, education level, alcohol use, tobacco use, and stage. Race, marital status, and cancer site differed only by PCS. Being female, never married, former alcohol user, or with stage IV disease significantly increased risk of a poor HR-QoL, with magnitudes of risk from 1.25- to 1.97-fold. Higher education level had a protective effect (MCS: P trend = 2.32 × 10−7; PCS: P trend = 5.62 × 10−14). Hispanics and African-Americans had a 1.35- and 1.57-fold risk of poor PCS, and increase in age had a protective effect for risk of poor MCS (P trend = 1.84 × 10−7). Poor MCS or PCS were associated with poor prognosis and decreased survival at 5 years (HRMCS 1.57, 95 % CI 1.41–1.76 and HRPCS 2.38, 95 % CI 2.08–2.72), and both remained significant when adjusting for age, gender, race, education level, tumor stage, and tumor site.
Conclusions
Our findings identify potential mediators for HR-QoL and suggest that baseline HR-QoL assessment may be prognostic for CRC.
Similar content being viewed by others
References
Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians,. doi:10.3322/caac.21332.
SEER cancer statistics review, 1975–2012, National Cancer Institute. (2015). SEER. http://seer.cancer.gov/csr/1975_2012/.
Schag, C. A., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994). Quality of life in adult survivors of lung, colon and prostate cancer. Quality of Life Research, 3(2), 127–141.
Sales, P. M., Carvalho, A. F., McIntyre, R. S., Pavlidis, N., & Hyphantis, T. N. (2014). Psychosocial predictors of health outcomes in colorectal cancer: A comprehensive review. Cancer Treatment Reviews, 40(6), 800–809. doi:10.1016/j.ctrv.2014.03.001.
Mols, F., Thong, M. S., van de Poll-Franse, L. V., Roukema, J. A., & Denollet, J. (2012). Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. Journal of Affective Disorders, 136(1–2), 26–34. doi:10.1016/j.jad.2011.08.034.
Zhang, J. K., Fang, L. L., Zhang, D. W., Jin, Q., Wu, X. M., Liu, J. C., et al. (2016). Type D personality is associated with delaying patients to medical assessment and poor quality of life among rectal cancer survivors. International Journal of Colorectal Disease, 31(1), 75–85. doi:10.1007/s00384-015-2333-4.
Kroz, M., Reif, M., Bussing, A., Zerm, R., Feder, G., Bockelbrink, A., et al. (2011). Does self-regulation and autonomic regulation have an influence on survival in breast and colon carcinoma patients? Results of a prospective outcome study. Health Qual Life Outcomes, 9, 85. doi:10.1186/1477-7525-9-85.
Vallance, J. K., Boyle, T., Courneya, K. S., & Lynch, B. M. (2014). Associations of objectively assessed physical activity and sedentary time with health-related quality of life among colon cancer survivors. Cancer, 120(18), 2919–2926. doi:10.1002/cncr.28779.
Cella, D., Cappelleri, J. C., Bushmakin, A., Charbonneau, C., Li, J. Z., Kim, S. T., et al. (2009). Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa. Journal of Oncology Practice, 5(2), 66–70. doi:10.1200/JOP.0922004.
Cella, D., Bushmakin, A. G., Cappelleri, J. C., Charbonneau, C., Michaelson, M. D., & Motzer, R. J. (2012). Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma. British Journal of Cancer, 106(4), 646–650. doi:10.1038/bjc.2011.589.
Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., et al. (2009). Baseline quality of life as a prognostic indicator of survival: A meta-analysis of individual patient data from EORTC clinical trials. The lancet Oncology, 10(9), 865–871. doi:10.1016/S1470-2045(09)70200-1.
Efficace, F., Bottomley, A., Coens, C., Van Steen, K., Conroy, T., Schoffski, P., et al. (2006). Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? European Journal of Cancer, 42(1), 42–49. doi:10.1016/j.ejca.2005.07.025.
Conroy, T., Bleiberg, H., & Glimelius, B. (2003). Quality of life in patients with advanced colorectal cancer: What has been learnt? European Journal of Cancer, 39(3), 287–294.
Mauer, M., Bottomley, A., Coens, C., & Gotay, C. (2008). Prognostic factor analysis of health-related quality of life data in cancer: A statistical methodological evaluation. Expert Review of Pharmacoeconomics & Outcomes Research, 8(2), 179–196. doi:10.1586/14737167.8.2.179.
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology, 26(8), 1355–1363. doi:10.1200/JCO.2007.13.3439.
Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38(10), 1351–1357.
Whynes, D. K., Neilson, A. R., Robinson, M. H., & Hardcastle, J. D. (1994). Colorectal cancer screening and quality of life. Quality of Life Research, 3(3), 191–198.
Ware, J, Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.
Cella, D. F., & Tulsky, D. S. (1993). Quality of life in cancer: Definition, purpose, and method of measurement. Cancer Investigation, 11(3), 327–336.
Conroy, T., & Blazeby, J. M. (2003). Health-related quality of life in colorectal cancer patients. Expert Review of Anticancer Therapy, 3(4), 493–504. doi:10.1586/14737140.3.4.493.
Ware, J. E, Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
Zack, M. M., & Centers for Disease, C., & Prevention. (2013). Health-related quality of life-United States, 2006 and 2010. MMWR Surveillance Summaries, 62(Suppl 3), 105–111.
Dunlop, D. D., Song, J., Lyons, J. S., Manheim, L. M., & Chang, R. W. (2003). Racial/ethnic differences in rates of depression among preretirement adults. American Journal of Public Health, 93(11), 1945–1952.
Tawk, R., Abner, A., Ashford, A., & Brown, C. P. (2015). Differences in colorectal cancer outcomes by race and insurance. International Journal of Environmental Research and Public Health,. doi:10.3390/ijerph13010048.
Yost, K. J., Hahn, E. A., Zaslavsky, A. M., Ayanian, J. Z., & West, D. W. (2008). Predictors of health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes, 6, 66. doi:10.1186/1477-7525-6-66.
Zahran, H. S., Kobau, R., Moriarty, D. G., Zack, M. M., Holt, J., Donehoo, R., et al. (2005). Health-related quality of life surveillance—United States, 1993–2002. MMWR Surveillance Summaries, 54(4), 1–35.
Arndt, V., Merx, H., Stegmaier, C., Ziegler, H., & Brenner, H. (2004). Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study. Journal of Clinical Oncology, 22(23), 4829–4836. doi:10.1200/JCO.2004.02.018.
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ, 316(7133), 736–741.
Barile, J. P., Mitchell, S. A., Thompson, W. W., Zack, M. M., Reeve, B. B., Cella, D., et al. (2015). Patterns of chronic conditions and their associations with behaviors and quality of life, 2010. Preventing Chronic Disease, 12, E222. doi:10.5888/pcd12.150179.
Religioni, U., Czerw, A., & Deptala, A. (2015). Acceptance of cancer in patients diagnosed with lung, breast, colorectal and prostate carcinoma. Iranian Journal of Public Health, 44(8), 1135–1142.
Owusu, D., Quinn, M., & Wang, K. S. (2015). Alcohol consumption, depression, insomnia and colorectal cancer screening: Racial differences. International Journal of High Risk Behaviors & Addiction, 4(2), e23424. doi:10.5812/ijhrba.4(2)2015.23424.
Scheithauer, W., Rosen, H., Kornek, G. V., Sebesta, C., & Depisch, D. (1993). Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ, 306(6880), 752–755.
Akyol, M., Ulger, E., Alacacioglu, A., Kucukzeybek, Y., Bayoglu, V., Yildiz, Y., et al. (2015). Quality of life in colorectal cancer patients: An Izmir Oncology Group (IZOG) study. Journal of BUON, 20(4), 1015–1022.
Sloan, J. A., Loprinzi, C. L., Kuross, S. A., Miser, A. W., O’Fallon, J. R., Mahoney, M. R., et al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Journal of Clinical Oncology, 16(11), 3662–3673.
Hilgenfeld, R. U., Streit, M., Thiel, E., & Kreuser, E. D. (1996). Current treatment modalities in advanced colorectal carcinoma. Recent Results in Cancer Research, 142, 353–380.
Earlam, S., Glover, C., Fordy, C., Burke, D., & Allen-Mersh, T. G. (1996). Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. Journal of Clinical Oncology, 14(1), 171–175.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Ward, W. L., Hahn, E. A., Mo, F., Hernandez, L., Tulsky, D. S., & Cella, D. (1999). Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument. Quality of Life Research, 8(3), 181–195.
Funding
Funding support for this study was provided in part by the NIH through MD Anderson’s Cancer Center Support Grant CA016672.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Reyes, M.E., Ye, Y., Zhou, Y. et al. Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Qual Life Res 26, 319–330 (2017). https://doi.org/10.1007/s11136-016-1381-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-016-1381-8